Description
9-Hydroxy-4-androstene-3,17-dione is an influential metabolic intermediate deployed in the compound industry is assumes a pivotal function in the amalgamation of diverse pharmaceutical agents. Frequently utilized in the research of hormone-responsive neoplasms encompassing breast and prostate cancers, it stands as a critical constituent for related drug advancement and exploration.
Synonyms
Androst-4-ene-3,17-dione, 9-hydroxy-; 9-Hydroxyandrost-4-ene-3,17-dione; 9α-Hydroxyandrost-4-ene-3,17-dione; Androst-4-en-9α-ol-3,17-dione; (8S,9R,10S,13S,14S)-9-hydroxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione
IUPAC Name
(8S,9R,10S,13S,14S)-9-hydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione
Molecular Formula
C19H26O3
Canonical SMILES
CC12CCC3(C(C1CCC2=O)CCC4=CC(=O)CCC43C)O
InChI
InChI=1S/C19H26O3/c1-17-9-10-19(22)15(14(17)5-6-16(17)21)4-3-12-11-13(20)7-8-18(12,19)2/h11,14-15,22H,3-10H2,1-2H3/t14-,15-,17-,18-,19+/m0/s1
InChIKey
SNMVJSSWZSJOGL-PLOWYNNNSA-N
Boiling Point
470.3±45.0°C at 760 mmHg
Melting Point
222-223.5°C